Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene …
Biotechnology
US, Philadelphia [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Passage Bio, Inc. has no acquisition track records yet.
M&A Deals · History
Passage Bio, Inc. has no acquisition track records yet.